Other Science

474 articles

Research
August 3, 2018 • 2 Min

Targeting Tumor Proteins Specific to Pancreatic Cancer Cells

A clinical trial tests the safety and effectiveness of tumor-associated antigen-specific cytotoxic T lymphocytes, which target specific tumor proteins.

Survivor Stories
October 14, 2019 • 5 Min

Learning to Guide My Pancreatic Cancer Treatment

The more Colin Gabriel learned about pancreatic cancer, the more he realized he needed to guide his treatment, rather than go where his HMO recommended.

Chemotherapy and Radiation
February 6, 2023 • 4 Min

Using Humor to Face Pancreatic Cancer

Richard Liles has a stage IV pancreatic cancer diagnosis but feels it is very important to keep a sense of humor throughout.

Research
June 13, 2018 • 2 Min

Testing the Effectiveness of Immunotherapy Added to a New Drug Combination

Researchers are testing a drug combination that adds immunotherapy to standard drugs used to treat pancreatic cancer and an antimalarial drug.

Research
May 4, 2018 • 2 Min

Testing Immunotherapy for Safety Before and After Pancreatic Cancer Removal

Researchers are testing a new monoclonal antibody to see if it helps patients with pancreatic tumors that can be surgically removed.

Research
January 24, 2018 • 2 Min

Chemoradiation Before Tumor Removal to Lessen Possible Post-Surgical Disease

A clinical trial examines the effectiveness of presurgical chemotherapy and radiation in making cancer-free margins after tumor removal.

Survivor Stories
June 19, 2019 • 5 Min

Twice Facing Pancreatic Cancer

Steven Lewis has faced down pancreatic cancer twice–first with a Whipple, chemo and radiation; then with liver surgery for metastasis.

Research
December 13, 2017 • 2 Min

Treating Tumors Before Pancreatic Cancer Surgery

Can neoadjuvant treatment such as chemoradiation make pancreatic cancer removal surgery more effective? That is the question asked by this clinical trial.

Research
November 30, 2017 • 2 Min

Testing an Experimental Combination of Drugs

A clinical trial for some cancers including pancreatic cancer tests the effectiveness of a checkpoint inhibitor and an antisense oligonucleotide inhibitor.